mmae · dm1 · exatecan-dxd
최대 4개 패밀리를 선택해 비교합니다.
Payload: mmae, mmaf
MMAE (auristatin) payload family. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
맵 열기 →Payload: dm1, dm4
DM1 / maytansinoid payload family. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
맵 열기 →Payload: dxd
Exatecan / DXd (TOP1 inhibitor) payload family. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
맵 열기 →Morgan fingerprint, radius 2, 2048 bits, Tanimoto. This value does not predict potency, biological activity, safety, or clinical efficacy.
| MMAE (auristatin) payload family | DM1 / maytansinoid payload family | Exatecan / DXd (TOP1 inhibitor) payload family | |
|---|---|---|---|
| MMAE (auristatin) payload family | 1.00 | 0.14 | 0.13 |
| DM1 / maytansinoid payload family | 0.14 | 1.00 | 0.11 |
| Exatecan / DXd (TOP1 inhibitor) payload family | 0.13 | 0.11 | 1.00 |
mmae · dm1 · exatecan-dxd
최대 4개 패밀리를 선택해 비교합니다.
Payload: mmae, mmaf
MMAE (auristatin) payload family. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
맵 열기 →Payload: dm1, dm4
DM1 / maytansinoid payload family. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
맵 열기 →Payload: dxd
Exatecan / DXd (TOP1 inhibitor) payload family. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
맵 열기 →Morgan fingerprint, radius 2, 2048 bits, Tanimoto. This value does not predict potency, biological activity, safety, or clinical efficacy.
| MMAE (auristatin) payload family | DM1 / maytansinoid payload family | Exatecan / DXd (TOP1 inhibitor) payload family | |
|---|---|---|---|
| MMAE (auristatin) payload family | 1.00 | 0.14 | 0.13 |
| DM1 / maytansinoid payload family | 0.14 | 1.00 | 0.11 |
| Exatecan / DXd (TOP1 inhibitor) payload family | 0.13 | 0.11 | 1.00 |